Related Experiment Video
Updated: Jun 11, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss
Jiayao Zhang1, Yun Zhai1, Liang He2
1Shanghai Engineering Research Center of Tooth Restoration and Regeneration & Tongji Research Institute of Stomatology & Department of Prosthodontics, Shanghai Tongji Stomatological Hospital and Dental School, Tongji University, Shanghai, China.
The miR-1a-3p-Fcgr4 axis links systemic stress to osteoporosis by regulating osteoclast activity. Reduced miR-1a-3p and increased Fcgr4 expression promote bone loss in stress models and human osteoporosis.
Area of Science:
- Immunology
- Bone Biology
- Molecular Biology
Background:
- Osteoporosis involves disrupted bone homeostasis between resorption and formation.
- Chronic systemic conditions can affect immune-bone interactions, but mechanisms are unclear.
Purpose of the Study:
- Investigate the role of miR-1a-3p and its target Fcgr4 in immune-mediated osteoclast dysregulation.
- Determine if psychological stress influences this axis in bone loss.
Main Methods:
- Bioinformatic prediction and dual-luciferase assays identified miR-1a-3p targeting Fcgr4.
- In vitro studies assessed miR-1a-3p effects on osteoclasts.
- Human cohorts and a chronic unpredictable mild stress (CUMS) model evaluated miR-1a-3p/Fcgr4 in osteoporosis and stress.
Main Results:
- miR-1a-3p directly targets and suppresses Fcgr4, inhibiting osteoclast activity.
- miR-1a-3p was downregulated in human osteoporosis and bone loss models.
- CUMS induced decreased miR-1a-3p, increased Fcgr4, activated FcγRIV-SYK-NFATc1 signaling, and exacerbated osteoporotic bone loss.
Conclusions:
- The miR-1a-3p-Fcgr4 axis connects systemic pathology to immune-mediated osteoclast dysfunction.
- This axis provides a mechanism for stress-induced bone loss and informs immune-bone interactions in chronic diseases.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...